ft_home

Banks seek to offload risk to avoid ‘choking’ on data centre debt

global banks are moving to offload some of their data centre debt, worried the ai boom is piling on more exposure than they can safely hold. they're using private deals and risk transfers to shrink their balance sheets without selling the loans outright.

the concern is that data centre construction — driven by the massive computing needs of ai — has created a wave of lending that could eventually "choke" banks if the sector turns. lenders are now shopping around portions of that debt to institutional investors, including insurers and pension funds, who are willing to take on the risk for a higher return.

the deals are structured as synthetic risk transfers, meaning banks keep the loans on their books but shift the credit risk to outside buyers. it's a quieter, less public way to manage exposure than a full sale. the volumes are still small relative to the overall market, but the activity signals banks are already bracing for a potential downturn in ai-related real estate.

source: ft_home
sentiment: -0.20 · impact: 0.60

Oil prices climb after disputed report of Iran strike on U.S. warship in the Strait of Hormuz

oil started the week higher on a disputed claim of an iranian strike on a u.s. navy ship in the strait of hormuz. the report, which hasn't been confirmed by u.s. officials, added fresh volatility to crude markets. the strait of hormuz is a key chokepoint

The markets are in the early stages of pricing in stagflation. Here’s what happens next.

source: marketwatch_top sentiment: -0.70 · impact: 0.80

Warsh's take on Fed independence is met with confusion and some concern

kevin warsh, trump's pick to lead the fed, is drawing confusion from six former fed officials over his views on fed independence. the sticking point: he draws a line between monetary policy — which he says should be "strictly independent" — and "non-monetary matters" like international

'Bubble effect': Weight loss drug fueled growth is putting the pharma sector at risk, report finds

the weight-loss and diabetes drug boom is creating a bubble risk for pharma, according to a deloitte report out monday. r&d returns for the top 20 pharma companies hit 7% for a third straight year, driven almost entirely by glp-1 drugs like wegovy and zepbound. strip those out

Read more

Oil prices climb after disputed report of Iran strike on U.S. warship in the Strait of Hormuz

The markets are in the early stages of pricing in stagflation. Here’s what happens next.

Warsh's take on Fed independence is met with confusion and some concern

'Bubble effect': Weight loss drug fueled growth is putting the pharma sector at risk, report finds